Home DNAmbiguous: FDA orders 23AndMe to submit its product for evaluation and efficacy testing
 

Keywords :   


DNAmbiguous: FDA orders 23AndMe to submit its product for evaluation and efficacy testing

2013-11-25 19:23:58| Extremetech

The FDA has yanked its approval of 23andMe's product, giving the company 15 days to produce data that demonstrates the efficacy of its testing or face further penalties.

Tags: product submit orders evaluation

Category:Information Technology

Latest from this category

All news

»
08.10Hurricane Milton Public Advisory Number 11A
08.10Summary for Hurricane Milton (AT4/AL142024)
08.10Eastern North Pacific Tropical Weather Outlook
08.10Atlantic Tropical Weather Outlook
08.10Wait longer for an electric taxi, says Uber boss
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10Customers of failed crypto firm FTX set for refunds
07.10Hurricane Milton Graphics
More »